These three groups are collectively called eicosanoids, derived from arachidonic acid via the cyclooxygenase (COX) or lipoxygenase pathways.
Thromboxanes are eicosanoids derived from arachidonic acid via the COX pathway, specifically from PGH2.
They play significant roles in hemostasis and vascular function.
Major Thromboxanes:
TXA2 (Thromboxane A2):
Functions: Promotes platelet aggregation and vasoconstriction, essential for blood clot formation.
TXB2 (Thromboxane B2):
Function: Inactive metabolite of TXA2, used as a marker for thromboxane production.
Synthesis:
Platelet Activation: Upon vascular injury, platelets release arachidonic acid.
COX Pathway: COX-1 in platelets converts arachidonic acid to PGH2.
Thromboxane Synthase: PGH2 is then converted to TXA2.
Pharmacological Effects:
Platelet Aggregation: Strongly promote platelet clumping, essential for blood clot formation.
Vasoconstriction: Cause narrowing of blood vessels, increasing blood pressure.
Hemostasis: Aid in stopping bleeding by facilitating clot formation at injury sites.
Examples:
TXA₂ (Thromboxane A₂): Potent inducer of platelet aggregation and vasoconstriction.
TXB₂: Inactive metabolite used as a marker for thromboxane production.